Impact of Back-to-Base Normothermic Machine Perfusion on Complications and Costs
Chase J Wehrle,Mingyi Zhang,Mazhar Khalil,Alejandro Pita,Jamak Modaresi Esfeh,Teresa Diago-Uso,Jaekeun Kim,Federico Aucejo,David CH Kwon,Khaled Ali,Beatrice Cazzaniga,Yuki Miyazaki,Qiang Liu,Sami Fares,Hanna Hong,Munkhbold Tuul,Chunbao Jiao,Keyue Sun,Robert L. Fairchild,Cristiano Quintini,Masato Fujiki,Antonio D. Pinna,Charles Miller,Koji Hashimoto,Andrea Schlegel
DOI: https://doi.org/10.1097/sla.0000000000006291
IF: 13.787
2024-04-01
Annals of Surgery
Abstract:Objective: Assess cost and complication outcomes after liver transplantation (LT) using normothermic machine perfusion (NMP) Summary Background Data: End-ischemic NMP is often used to aid logistics, yet its’ impact on outcomes after LT remains unclear, as does its’ true impact on costs associated with transplantation. Methods: Deceased donor liver recipients at two centers (1/1/2019-6/30/2023) were included. Retransplants, splits and combined grafts were excluded. End-ischemic NMP (OrganOx-Metra®) was implemented 10/2022 for extended-criteria DBDs, all DCDs and logistics. NMP-cases were matched 1:2 with cold storage controls (SCS) using the Balance-of-Risk (DBD-grafts) and UK-DCD Score (DCD-grafts). Results: Overall, 803 transplantations were included, 174 (21.7%) receiving NMP. Matching was achieved between 118 NMP-DBDs with 236 SCS; and 37 NMP-DCD with 74 corresponding SCS. For both graft types, median inpatient comprehensive complications index (CCI) values were comparable between groups. DCD-NMP grafts experienced reduced cumulative 90-day CCI (27.6 vs. 41.9, P =0.028). NMP also reduced the need for early relaparotomy and renal-replacement-therapy, with subsequently less-frequent major complications (Clavien-Dindo > IVa). This effect was more pronounced in DCD-transplants. NMP had no protective effect on early biliary complications. Organ acquisition/preservation costs were higher with NMP, yet NMP-treated grafts had lower 90-day pre-transplant costs in context of shorter waiting-list times. Overall costs were comparable for both cohorts. Conclusions: This is the first risk-adjusted outcome and cost analysis comparing NMP and SCS. In addition to logistical benefits, NMP was associated with a reduction in relaparotomy and bleeding in DBD-grafts, and overall complications and post-LT renal-replacement for DCDs. While organ acquisition/preservation was more costly with NMP, overall 90-day-healthcare costs-per-transplantation were comparable.
surgery